Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
LaunchKC lands keynote speaker from NASA; Techweek queries two Google developer advocates
Pitch Day for LaunchKC is expected to lift off next month with an opening keynote address from NASA executive Kira Blackwell. Remarks are expected to delve into NASA iTech, a year-long effort to find innovative ideas that address challenges and fill gaps in five critical areas identified by the space agency as having a potential impact…
CBD startup: Young father sees Native Hemp Co. as the launch of a health revolution
At 21 years old, Rich Dunfield IV felt like an absentee father, he said. Struck in his prime with painful ailments after a tick bite — nerve and belly problems, anxiety and depression — he was home but not present. “My entire life was rooted in fatherhood. I started young, but I embraced it. Lyme…
New Lawrence Blade & Timber just the edge of Swell Spark’s ongoing brand evolution
A newly opened Lawrence Blade & Timber — well-positioned on the college town’s popular Massachusetts Street — features the axe-throwing brand’s first “retailtainment” concept. It’s a reflection of parent company Swell Spark’s ongoing push to keep Blade & Timber (as well as the Choir Bar and Breakout businesses) fresh amid an increasingly crowded experience-based entertainment…
25th anniversary: Roasterie founder Danny O’Neill recalls humble start with just ‘nickels and pickles’
Brewed in a recession, Danny O’Neill wasn’t sure The Roasterie would sell a single cup of coffee, let alone percolate into an iconic Kansas City brand, the founder said as he reflected on the regional coffee titan’s 25th anniversary. “The only idea I had was coffee,” O’Neill said of his decision to jump ship from…